✦ LIBER ✦

Phase II trial of pegylated-liposomal doxorubicin in the treatment of locally advanced unresectable or metastatic transitional cell carcinoma of the urothelial tract

✍ Scribed by E. Winquist; D.S. Ernst; D. Jonker; M.J. Moore; R. Segal; G. Lockwood; A. Rodgers

Book ID: 117660092
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 161 KB
Volume: 39
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(03)00358-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated liposomal doxorubicin as third

Pegylated liposomal doxorubicin as third-line chemotherapy in patients with metastatic transitional cell carcinoma of urothelial tract: results of a phase II study

✍ Antonio Rozzi, Daniele Santini, Margherita Salerno, Francesca Bordin, Andrea Man 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 255 KB

Non-pegylated liposomal doxorubicin comb

Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial

✍ S. Del Barco; R. Colomer; L. Calvo; I. Tusquets; E. Adrover; P. Sánchez; J. Rifà 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 220 KB

A phase I/II trial of non-pegylated lipo

A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer

✍ D. Amadori; C. Milandri; G. Comella; S. Saracchini; S. Salvagni; C. Barone; R. B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Phase II trial of intermediate dose meth

Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma

✍ Paul M. Dodd; John A. McCaffrey; Madhu Mazumdar; Howard Scher; Vaia Vlamis; Gera 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 3 views

## Background: This study was undertaken to determine whether the use of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin as first-line therapy increases the proportion of major responders and overall survival in patients with unresectable or metastatic tra

Phase II Study of Bortezomib and Pegylat

Phase II Study of Bortezomib and Pegylated Liposomal Doxorubicin in the Treatment of Metastatic Breast Cancer

✍ William J. Irvin Jr.; Robert Z. Orlowski; Wing-Keung Chiu; Lisa A. Carey; France 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 766 KB

Phase II Study of Carboplatin in Locally

Phase II Study of Carboplatin in Locally Advanced and Metastatic Transitional Cell Carcinoma of the Urinary Bladder

✍ N. K. RAABE; SOPHIE D. FOSSÅ; G. PARØ 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB